Abstract
Workers with cardiac active implantable medical devices (AIMD), such as a pacemaker (PM) or an implantable defibrillator (ICD), are considered by the occupational health and safety regulation framework as a particularly sensitive risk group that must be protected against the dangers caused by the interference of electromagnetic field (EMF). In this paper, we first describe the general methodology that shall be followed for the risk assessment of employees with a cardiac AIMD exposed to EMF, according to the EU regulation, and in particular to the EN 50527-2-1:2016 and 50527-2-2:2018 standards. Then, three case studies related to specific EMF sources are presented, to better describe how the initial analysis of the risk assessment can be performed in practice, and to understand if a further specific risk assessment analysis is required or not.
Funder
Istituto Nazionale per l'Assicurazione Contro Gli Infortuni sul Lavoro
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference33 articles.
1. Directive 89/391/EEC of the European Parliament and of the Council of 12 June 1989 on the Introduction of Measures to Encourage Improvements in the Safety and Health of Workers at Work
https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A31989L0391
2. Directive 2013/35/EU of the European Parliament and of the Council of 26 June 2013 on the Minimum Health and Safety Requirements regarding the Exposure of Workers to the Risks Arising from Physical Agents (Electromagnetic Fields) (20th Individual Directive within the Meaning of Article 16
3. (1) of Directive 89/391/EEC) and Repealing Directive 2004/40/EC https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32013L0035
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献